Minnelide Along With Abraxane Plus Gemcitabine in Patients With Metastatic Adenocarcinoma of the Pancreas
Clinical trial NCT05557851 · UNKNOWN
Trial details
- NCT number
- NCT05557851
- Sponsor
- Minneamrita Therapeutics LLC
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-01
- Primary completion
- 2024-06-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.